Contents

1. Get Involved ................................................................................................................................................. 2

2. The Project ................................................................................................................................................... 2

3. Structure ....................................................................................................................................................... 3

4. Target Audience .......................................................................................................................................... 3

4. Schedule for Development ...................................................................................................................... 3

1. Promotion ..................................................................................................................................................... 4

5. Industry Essentials ...................................................................................................................................... 4

Annexe 1: ACVC Essentials 4 You Preliminary Programme .................................................................... 6

2

1. Get Involved

In line with the ACVC’s mission and following the very sensitive COVID-19 situation, the objective of this project is to make time sensitive scientific resources (publications, slides, e-Abstracts) available for consultation online to all healthcare professionals1.

▪ New scientific content to be posted every week

▪ Provide HCPs worldwide with access to scientific resources from any region of the globe

▪ Keep the community tuned in during the COVID-19 outbreak: content will be offered as a Stop and Watch resource to HCPs to stay abreast of essential science during COVID-19 crisis.

▪ Update professionals on the latest scientific content in the field of acute cardiovascular care

▪ Reach out to a wider professional audience through free access

▪ Offer industry partners the opportunity to actively participate in this special scientific platform by posting their own Industry content to be hosted on the dedicated ACVC Essentials 4 You platform

▪ The resources uploaded on the ACVC Essentials 4 You platform will also be uploaded and archived on the renowned ESC 365 platform (over 3.73 million resources consulted by 95,000 unique users since launch)

2. The Project

In the current health crisis, ACVC is here to help Healthcare professionals stay up to date on the latest scientific developments in preventive cardiology. ACVC Essentials 4 You is a comprehensive collection of valuable and carefully selected resources. ACVC members will benefit from year-round access to these resources while non-members will still have the opportunity to discover the high value of this scientific content for 3 months (until 16 July 2020). Uploading Essentials 4 You resources on the ESC 365 platform will significantly increase their visibility while offering users the possibility of using the variety of functionalities the platform offers (e.g. bookmark favourite resources for future reference, rate the presentation, discover more information about the speaker). This will also allow cross-promotion with other ACVC resources added on this platform over the past 5 years to present users with the wealth of scientific content ACVC has to offer. This platform will become THE comprehensive hub for all scientific content related to acute cardiovascular care. The ACVC Essentials 4 You platform will gather the following content online: 1. Publications (e-Abstracts) 2. Industry Essentials (latest resources from industry partners in the field) 3. Any other scientific content identified by the ACVC Scientific committee from 16 April to 16 July Other sections will be added online related to the content published such as: • Link to online Abstract Supplement of the ACVC Journal (available in June 2020) • Social Media Wall

1 HealthCare Professionals (HCPs). The target audience will be all the HCPs dealing with patients in the acute setting.

3

The platform will be optimised for computer and mobile devices, with VOD content available at: https://www.escardio.org/Sub-specialty-communities/Association-for-Acute-CardioVascular-Care-(ACVC)/Research-and-Publications/ACVC-Essentials-4-You

3. Structure

• Scientific Committee Structure 2018-2020

▪ Chairperson: Doctor Sergio Leonardi – Co-Chairperson: Doctor Konstantin Krychtiuk ▪ The ACVC Scientific committee has appointed 2 coordinators who will approve the programme

outline ▪ All resources will have to be validated upfront by the ACVC Scientific committee. The following

information will be requested: Title of the session, titles of the presentations, name of the speakers, learning objectives.

• Calendar

The ACVC Essentials 4 You webpage was launched on Thursday 16 April 2020. New scientific content will be added online on a weekly basis upon reception from contributors.

• Format 3 types of formats can be submitted:

• PowerPoint file • Video including speaker voice over and slides (MP4) • Video created from several PowerPoint files with voice over (MP4)

Multiple presentations can be submitted for a single session. We recommend that the format of the content should not exceed 45 minutes for optimal use on the web. Content must be in English. Industry Essentials will be uploaded within 24 hours (working days) upon reception.

4. Target Audience

ACVC Essentials 4 You is designed for:

• Cardiologists

• Cardiologists in training

• Fellows in the field of acute cardiovascular care

The target audience will be all the above-mentioned HealthCare Professionals that are interested in acute cardiovascular care, experts from emergency medicine, intensive care, anaesthetics, radiology, nursing, medical technology, paramedics, as well as those who participate in Acute CVC Congresses.

4. Schedule for Development

➢ ACVC Essentials 4 You has been launched on 16 April 2020 ➢ Industry Essentials published online on a weekly basis until 16 July (with possibility for Industry to

recommend a date for publication particularly in case of embargo issues) ➢ Industry Essentials available online for 1-year duration on ACVC Essentials 4 You

4

1. Promotion

• Feature in ACVC news bulletins: Events, Science & Education – sent to all subscribers – interested in Acute Cardiovascular Care

• Feature in some of My ESC weekly Newsletters – sent to 67 000 subscribers

• Feature in some of ESC NCS monthly President letters – sent to all NCS Presidents of 56 ESC National Cardiac Societies (NCS) representing 70 pax

• Dedicated webpage on ESC website hosted on the ACVC homepage section

• Active Social media promotion on ESC accounts in Twitter (#ACVCessentials4U), Facebook & LinkedIn (dedicated campaigns)

• Google AdWords daily campaigns

• Promotion (seamless access) on ESC 365 platform

5. Industry Essentials

Industry Partners are invited to contribute their cutting-edge science to our dedicated platform (& consequently also on ESC 365 platform) by providing resources of their session(s) as follows: • Industry Essentials represent a session that can be sequenced in several presentations e.g. 4x15 mins or 4 x 10 mins or 3 x20 mins or 2x30 mins... (see 3. Structure for resource types) • Industry Essentials are only available for hot topics/late-breaking science: providing a new perspective related to innovations or findings (the programme = title, learning objectives, is subject to ACVC Scientific Committee approval) • Recordings are hosted on ACVC Essentials 4 You webpage for 12 months as well as on the ESC 365 platform. • Require Scientific Committee validation. Three session product options are available:

a. Industry Essentials – Dissemination Industry provides their ready-made resources (videos in .mp4) of their session(s) to be uploaded on ACVC Essentials 4 You and ESC 365. Price per session: €10,000

b. Industry Essentials – Post-production & dissemination Industry provides session files to ESC and our selected studio provider for post-production & dissemination through ACVC Essentials 4 You and ESC 365. Example: https://youtu.be/qNKsr51vxpQ Presentations can contain slides only, slides & speakers’ voice over or slide & video recording of speaker (all files should be provided by the industry) Price per session: €15,000

c. Industry Essentials – Full Production & dissemination Industry provides session slides to ESC and our selected studio provider to produce the session recording & dissemination through ACVC Essentials 4 You and ESC 365. Slides shall be provided 3 days prior to recording. Speaker coordination is organised by supporting industry. Example: https://youtu.be/crxtEVLJ7oQ Price per session: €20,000 Benefits: Industry Essentials sponsors are entitled to the following benefits:

5

• Full report including VOD statistics and viewership insights (subject to availability in MyESC accounts) will be sent to the sponsor(s) 3, 6 months and 12 months post publication online

• Platform will be promoted to targeted audiences (see 6. Promotion)

• Opportunity for sponsor to promote the platform and their related content on the platform.

• Questions and Answers (Q&A) form: A Q&A form will be available next to the Industry Essentials resources in order to collect all questions from the audience. Sponsors will be able to post their answers using this platform. d. Sponsorship opportunities

In addition to the previous product options, ESC proposes a range of sponsorship opportunities to increase the visibility of your activities on the ACVC Essentials 4 You platform:

Promotional Banner on ACVC Essentials 4 You – €7,500 per week On a weekly basis, sponsors can place their banner at the top of the ACVC Essentials 4 You platform for optimal exposure. This banner will be clickable and will lead to the industry session page.

eBlast - €5,000 A customised mailing will be sent to the ACVC community on 17 June. Email will be sent to 59,000+ healthcare professionals with an interest in:

• Acute Cardiac Care

• Acute Coronary Syndromes

• Acute Heart Failure

• ACVC members & communication subscribers This email allows you to promote your session(s) on ACVC Essentials 4 You. Each eBlast is limited to 10 advertising slots Push your session – €2,000 On a weekly basis you can place your session at the top of the list of the Industry Sessions. Sessions will be sorted by alphabetical order of Company Name.

6

Annexe 1: ACVC Essentials 4 You Preliminary Programme

Below is the list of content identified as of 28/04/2020 to be published on this project. This content is still preliminary and is subject to change.

The scientific committee will continue to select new content to post online from 16 April - 16 July. The content will be published gradually on a weekly basis in order to bring new content to the scientific community every week.

a. Publications (E-Abstracts)

• A case series of left Impella-device as bridge from acute mitral regurgitation to MitraClip-procedure: a novel implementation of percutaneous mechanical circulatory support

• A matter of time: identifying optimal surgical timing for ischemic ventricular septal rupture repair.

• A new strategy to guide VA ECMO weaning. Provisional results of a pilot study.

• A novel district hospital rapid access ambulatory cardiology clinic - a prospectively collected audit

• Absorbable antibacterial envelope for the prevention of cardiac implantable electronic device infection in high risk patients: what is our reality?

• Acceptance of the illness and readiness for hospital discharge of patients after acute myocardial infarction

• Accuracy of Oesil, Rose and San Francisco scores for syncope stratification in the emergency unit

• Accuracy of precordial ECG lead placement by nurses in the emergency department.

• Acute coronary syndrome in the setting of multimorbidity

• Acute coronary syndrome in young women: characteristics, etiology and in-hospital outcomes

• Acute Coronary Syndromes in young patients

• Acute coronary syndromes without st elevation and chronic kidney disease: prognostic implication of an early invasive angiographic approach

• Acute neurological complications in adult patients with cardiac dysfunction on veno-arterial extracorporeal membrane oxygenation support

• Adrenaline use and associated short-term prognosis in a multicenter cohort of cardiogenic shock patients

• Analysis of complications in patients supported with veno-arterial extracorporeal membrane oxygenator and its influence on survival.

• Analysis of the effectiveness of Chest Pain Alert Algorithm and HEART score for the detection of acute coronary syndrome in patients with chest pain presenting to the emergency department

• Angioplasty with stenting in acute coronary syndromes with very low contrast volume (<30ml) using cordis 6f diagnostic catheters and improved clinical outcomes

• Anisocytosis predicts postoperative renal replacement therapy in patients undergoing heart valve surgery

• Anticoagulation in patients with VA-ECMO, is it safe to defer it?

• Anti-inflammatory Effects of Tanshinone IIA on Ox-LDL Injured Endothelial Cells are Mediated by Estrogen Receptor Activation and Through MAPK Pathway

• Antithrombotic management in transaortic valve implantation: who need what? A historic cohort study

• Antithrombotic therapy in cardiogenic shock: a Portuguese National analysis

• Are the risk criteria for syncope ultimately applied in real life?

7

• Assessment of circulating biomarkers levels in heart failure patients with restored ejection fraction: an explorative proteomic-based approach

• Association between clinical risk score (HEART, GRACE and TIMI) and angiographic complexity in acute coronary syndrome without ST-segment elevation

• Association id polymorphism of a gene angiotension-converting enzyme in development of atrial fibrillation

• Association Met235Thr polymorphism of a gene AGT in development of atrial fibrillation

• Association polymorphism A/C of a gene AGTR1 in development of atrial fibrillation

• Association T174M polymorphism of a gene AGT in development of atrial fibrillation

• ATRIA score predicts survival in the first year after stent implantation in patients with atrial fibrillation

• Awake venoarterial extracorporeal membrane oxygenation in cardiogenic shock: a propensity score matched analysis

• Biomarkers of brain injury measured at admission after out-of-hospital-cardiac-arrest have similar prognostic accuracy as wildly known intensive care scores

• Biomarkers reflecting neurohormonal activation and inflammation are correlated with the ORBI Risk Score and predictive of in-hospital cardiogenic shock development in STEMI-patients

• Can genetic variants associated to coronary artery disease risk be involved in the arterial plaque development?

• Cardiac arrest and non-diagnostic ECG: analysis of the usual practice of a tertiary care hospital

• Cardiac arrest in cardiogenic shock

• Cardiac arrest: which patients can benefit from coronary angiography?

• Cardiac arrhythmias do not predict the outcome in patients with cardiogenic shock and an impella assist device

• Cardiac rehabilitation following acute myocardial infarction and its impact on health-related quality of life

• Cardiogenic shock and coagulation profile

• Cardiogenic shock due to predominantly right ventricular failure following myocardial infarction

• Cardiogenic shock patients presenting with and without out of hospital cardiac arrest are different clinical entities

• Causes of death after ECMO weaning and predictors of survival to hospital discharge

• Central venous catheter associated thrombosis in critically ill patients

• Characteristics, management and in-hospital outcomes of patients with spontaneous coronary artery dissection (SCAD).

• Characterization of the population with infectious endocarditis and its evolution over the years.

• Characterization, management and prognosis of elderly patients admitted with sudden cardiac death

• Chest ultrasound for the differential diagnosis of acute cardiogenic dyspnoea among patients admitted to an intensive care unit: a comparison with natriuretic peptides

• Chronobiological profile of takotsubo syndrome

• Clinical associations of intramyocardial haemorrhage and microvascular obstruction in primary myocardial infarction with ST-segment elevation

• Clinical characteristics of pericarditis and myopericarditis diagnosed in the emergency department: factors associated with myocardial involvement and the need for hospitalization.

• Clinical picture, management and risk stratification in patients with cardiogenic shock: does gender matter?

• Clinical profiles, outcome and prognostic factors of patients treated with percutaneous left ventricular assist devices (Impella) for protected PCI and cardiogenic shock

8

• Clinical, angiographic and treatment characteristics of patients discharged alive after acute myocardial infarction and cardiac arrest

• Comparison of antiplatelet therapy scenarios in ST segment elevation myocardial infarction in real clinical practice

• Comparison of different bleeding risk scores for predicting in-hospital major bleeding after thrombolytic therapy in patients with acute pulmonary embolism

• Comparison of long-term mortality of acute coronary syndrome patients base on the type of medical transport

• Comparison of relative fat mass index with other obesity parameters in predicting clinical severity and prognosis of acute myocardial infarction

• Comparison of the course and clinical events in patients with acute heart failure in the context of acute coronary syndrome depending on the use of artificial ventilation

• Compensatory mechanisms of gene regulation in response to chronic stress

• Concomitant chronic total occlusion (CTO) as a prognostic factor for the immediate and long-term prognosis of patients with myocardial infarction with ST-elevation (STEMI)

• Coronary artery ectasia, an independent predictor of high thrombus burden in patients presenting with ST-elevation myocardial infarction

• Coronary slow flow is associated with a worse clinical outcome in patients with takotsubo syndrome

• Correlating novel biomarkers sST2 and IL-33 with levels of circulating dendritic cells in patients with acute myocardial infarction

• Creating a score to predict advanced AV block in patients with acute coronary syndrome

• CRUSADE score and age: which is hot and which is not for bleeding prediction in acute coronary syndromes

• Decline of mortality associated to acute coronary syndromes: what can we still improve?

• Diabetes mellitus and out-of-hospital cardiac arrest: single center experience

• Diagnostics of myocardial arrhythmogenic activity in setting of ischemia using magnetocardiographic mapping

• Does coronary calcium scoring adds value to cardiovascular risk prediction in asymptomatic population?

• Dual antiplatelet therapy-related haematuria after acute coronary syndromes- etiology, management and outcomes in our casuistry

• Duration of hospitalization in acute pulmonary embolism

• Dynamic changes of troponin and creatinine phosphokinase in acute myocarditis and non-ST elevation myocardial infarction

• Dynamics of antithrombotic therapy administration rate and potential adherence to treatment in patients with atrial fibrillation during the acute phase of myocardial infarction

• Early discharge within 48 to 72 hours following acute ST elevation myocardial infarction and primary PCI is not associated with high mortality rates or major adverse cardiovascular events for low Risk

• Early prognosis after out of hospital cardiac arrest based upon biomarkers of brain injury measured at admission to hospital.

• Early ventricular fibrillation in Acute Coronary Syndrome. The role of previous antiplatelet therapy.

• Evaluation of patients with initial suspicion of tako-tsubo cardiomyopathy: a seven-year prospective study

• Evaluation of predictors of higher fibrosis percentage among admitted patients with unstable acute ischemic syndrome. Would Morphine use be an independent predictor?

• Exhaled breath acetone as a marker for acute heart failure in patients presenting with breathlessness

9

• Experience in emergent percutaneous coronary interventions in pediatric population in a congenital cardiac disease centre.

• Experience of using FOCUS in a multidisciplinary hospital.

• Familial hypercholesterolemia prevalence between early-onset coronary artery disease patients in Lithuania and influence of known cardiovascular risk factors

• Fast prehospital rule-out using a high-sensitivity cardiac troponin T assay in a low-prevalence population for acute coronary syndrome (OUT-ACS)

• First russian registry of pulmonary embolism sirena

• Fluid therapy in non-septic acute decompensated heart failure patients and in- hospital mortality

• Fragmented QRS complex and ventricular arrhythmias in patients with myocardial infarction

• Gender influence in prediction of cardiogenic shock after an acute coronary syndrome.

• Glycaemic status in ST elevation myocardial infarction and long-term mortality: prediabetes and controlled diabetes mellitus two sides of the same coin?

• Heart rate on admission and one-year outcomes of Killip class 1 patients with acute myocardial infarction and sinus rhythm

• Hemodynamics and vasopressor support during prolonged targeted temperature management after out-of-hospital cardiac arrest

• Hemodynamics during Impella-protected PCI in high risk patients with reduced ejection fraction and multi-vessel disease

• High venous to arterial CO2 gap is related to cardiovascular death in cardiogenic shock

• High-sensitivity C-reactive protein and acute kidney injury in patients with acute myocardial infarction.

• Hypoalbuminemia in patients with VA-ECMO: incidence and prognostic value

• Identification of a major bleeding predictive score in acute coronary syndrome

• Immediate and long-term predictors of outcomes in left main percutaneous coronary intervention: a center experience

• Immediate cardiopulmonary responses in consecutive, acute pulmonary embolism

• Impact of preprocedural TIMI flow on clinical outcome in acute ST elevation myocardial infarction patients with single vessel disease after primary percutaneous coronary intervention

• Impact of comorbidities on outcome of patients with ST elevation myocardial infarction

• Impact of concomitant chronic total occlusion (CTO) on the immediate and long-term prognosis of patients with myocardial infarction without ST-elevation (NSTEMI)

• Impact of Levosimendan use on the success of weaning and survival of patients with veno-arterial extracorporeal membrane oxygenator.

• impact of off-hour presentation on in-hospital mortality of patients with acute ST-Segment Elevation Myocardial Infarction treated with primary angioplasty in a region without STEMI network

• Impact of total ischemic time on in-hospital complications in patients undergoing primary percutaneous coronary intervention with acute ST-segment elevation myocardial infarction

• Impact of vascular disease in the short-term prognosis of patients who underwent hypothermia after cardiac arrest.

• Impella RP support in refractory right ventricular failure complicating acute myocardial infarction with unsuccessful right coronary artery revascularization

• Inadequate left ventricular unloading during venoarterial extracorporeal membrane oxygenation: a ten-year experience in a tertiary hospital

• Incidence and prognostic relevance of new-onset atrial fibrillation in acute myocardial infarction and its relationship with renal function.

10

• Indicators of adrenoreactivity of erythrocyte membranes in patients with myocardial infarction and nonobstructive atherosclerosis of the coronary arteries in comparison with the control group

• Influence of Circulatory Support in Ventricular Septal Rupture After Acute Myocardial Infarction. Results from a Multicentre Registry of 105 patients.

• Influence of daylight- saving time on myocardial infarction rate? Data from a regional myocardial infarction registry

• Intra-aortic balloon counterpulsation: experience in a center without advanced mechanical circulatory support devices

• Intracardiac thrombosis and early remodeling in stemi patients associated with pro-inflammatory profile ofmonocytes subpopulation

• Intra-hospital LDL-c determination usefulness to predict the probability of achieving objective LDL-c after discharge in patients with acute coronary syndrome treated with high intensity statins

• Kids save lives in Greece-National training program of schoolchildren in cardiopulmonary resuscitation: evaluating the impact of a nationwide educational seminar in a cohort

• Lactate clearance as a predictor of neurological outcome and mortality in post cardiac arrest survivor treated with targeted temperature management during early phase of post cardiac arrest syndrome;

• Left main percutaneous coronary intervention with second generation drug-eluting stents

• Left ventricular remodeling in low and intermediate risk Non-STEMI pacients: immediate versus delayed reperfusion.

• Levosimendan in acute heart failure: a single-center experience

• Long-term IABP in end-stage CHF : a forgotten bridge?

• Long-term CAD events rate according to CAC scoring burden, in asymptomatic population

• Long-term outcomes comparison of percutaneous coronary intervention with two differents paclitaxel eluting balloon catheters.

• Long-term prognostic value of soluble urokinase plasminogen activator receptor in acute coronary syndromes

• Lung ultrasound predicts in-hospital mortality in acute heart failure

• Major neurological events associated with the use of extracorporeal membrane oxygenation devices in the coronary unit

• Management of right ventricular failure in patients with short-term left ventricular support devices. One-center experience.

• Mechanical circulatory support with VA-ECMO in post-cardiotomy shock, what is the current situation?

• Mechanical complications after myocardial infarction: uncommon but still lethal.

• Mechanical thrombectomy in combination with glycoprotein IIb/IIIa inhibitors with or without stent implantation in patients presenting with STEMI and high thrombus burden

• Mechanical ventilation in cardiogenic shock: association between positive pressure ventilation and outcomes according to invasive hemodynamics.

• Metabolomics profiles of ventricular fibrillation versus asphyxial cardiac arrest

• MINOCA before 2017 ESC clinical practice guidelines: an opportunity for improvement

• Modifiable risk factors and mortality outcomes in stroke patients: a systematic review and meta-analysis

• Modulating preload in acute pulmonary embolism

• Monocyte subset distribution is associated with outcome in patients after cardiac arrest

• Mortality and futility in patients withvenoarterial extracorporeal oxygenation membrane in a high volume tertiary center

• Mortality associated to acute coronary syndromes: a retrospective analysis of the last 5-years

11

• Myeloperoxidase predicts recurrent coronary events in patients after acute myocardial infarction

• Myocardial inflammation: Is the use of anti-inflammatory medication harmful?

• Neurohormonal activation is higher at hospital admission in women compared to men with ST-elevation myocardial infarction

• Neurologic evolution and prognosis in patients discharged from hospital after sudden cardiac death. 1 year-follow-up

• Non st elevation myocardial infarction in acute left circumflex occlusion - prognostic impact of a concealed severity

• Novel logistic risk score combining clinical assessment and neuron specific enolase in early prediction of death after out-of-hospital cardiac arrest.

• NSTEMI course depending on GRACE scale risk and ST2 plasma level

• Occluded culprit in non-ST-segment elevation myocardial infarction: characteristics and mortality

• Outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction complicated by cardiogenic shock.

• Outcomes and implications for clinical management of atrial fibrillation in critically ill patients admitted to a medical stepdown unit.

• Outcomes of pharmacoinvasive strategy compared with primary angioplasty in a large metropolitan area

• Patient's awareness of Idarucizumab and subsequent preference over anticoagulation.

• Peculiarities of clotting and endogenous fibrinolysis in patients with a history of spontaneous reperfusion of infarct-related artery.

• Percutaneous coronary intervention of in-stent restenosis lesions with second-generation drug coated balloons: Results at a long-term follow-up.

• Percutaneous coronary intervention with second-generation drug coated balloons in elderly patients: results at long-term follow-up.

• Persistent coma at 72 hours in survivors of out-of-hospital cardiac arrest treated by targeted temperature management predicts unfavourable six-month neurologic outcomes

• Pharmaco-invasive strategy in patients with STEMI according to a randomized clinical trial FRIDOM1 with a 1-year mortality estimate.

• PLIN2 protein expression is an age dependent regulator of plaque instability in ST-elevation myocardial infarction

• Polymorphic allelic variant 9 of a chromosome in association with development of an ischemic stroke

• Polymorphic allelic variant of a gene of a MTHFR with development of an ischemic stroke in patients with an arterial hypertension

• Poster not presented onsite, available on ESC365 - Usefulness of PESI score to predict clinical outcomes among intermediate risk pulmonary emboli patients

• Predictores of early cardiotoxicity induced by anthracyclines

• Predictors of coronary artery disease severity in non-ST segment elevation myocardial infarction

• Predictors of de novo atrial fibrillation in patients with septic shock

• Predictors of early death in high risk acute heart failure patients treated with levosimendan

• Preoperative angiotensin receptor-neprilysin inhibitors in patients undergoing Mitraclip implantation

• Pro-atrial natriuretic peptide is associated with mortality in patients with congestive heart failure admitted with st-elevation myocardial infarction

• Procedure Volume and Outcomes in Patients with VA-ECMO Support

• Profile of patients admitted in the Intensive Cardiac Care Unit of a large general hospital

12

• Prognosis of patients hospitalized with STEMI: does BNP help in the stratification?

• Prognostic approach of natriuretic peptides in acute heart failure

• Prognostic impact between age and time to coronary angiography in patients with type 2 infarction.

• Prognostic impact of BNP in patients presenting with STEMI and cardiogenic shock.

• Prognostic value of contrast volume/clearance of creatinine ratio as predictors of acute kidney injury and risk of long-term cardiovascular events.

• Prognostic value of microhemodynamic parameters of the early post-operatory in cardiac surgery of infective endocarditis

• Radiation eliminating 3D catheter tracking system and atrial flutter ablation; a single centre experience

• Real world data of ticagrelor in acute coronary syndrome: does it translate into better prognosis?

• Real-world data from a large multicenter registry of coronary lithoplasty for treatment of calcified lesions

• Relationship between admission Q waves and microvascular injury in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention

• Relative impact of left ventricle ejection fraction and functional NYHA class at discharge after acute myocardial infarction on 3-year outcomes (analysis from the PL-ACS registry)

• Repeated coronary catheterization after distal transradial intervention for patients with acute myocardial infarction

• Repetitive use of levosimendan in outpatients with end-stage heart failure: is this a bridging or palliative therapy?

• Results of percutaneous coronary intervention in de-novo coronary lesions with second-generation drug-coated balloons at a long-term follow-up.

• Results of percutaneous coronary intervention with second-generation drug coated balloons at a long-term follow-up.

• Results of percutaneous coronary intervention with second-generation drug coated balloons in diabetic patients at a long-term follow-up.

• Results of urgent percutaneous coronary intervention to non-protected left main coronary artery

• Revascularization strategies in cardiogenic shock after acute myocardial infarction

• Right heart thrombi in pulmonary embolism patients

• Right ventricular adaptation in acute pulmonary embolism

• Risk of severe bleeding in cancer patients undergoing pulmonary embolism thrombolysis. Does the presence of metastases make treatment unviable?

• Risk stratification of patients with acute pulmonary embolism and a low-moderate risk as per PESI score

• Role of echocardiography hemodynamic measurement as a predictor of in-hospital mortality in ST-elevation myocardial infarction patients

• Role of macrophage-produced bone morphogenetic proteins in patients with acute primary STEMI: from experiment to clinic.

• Safety of percutaneous dilatational tracheotomy in patients on dual antiplatelet therapy and anticoagulation

• Severe and deadly: a decade of infective endocarditis

• Sex gaps in optimal care delivery after acute coronary syndromes in a tertiary center in europe: (not) me too

• Sex-differences in the baseline characteristics, treatment and mortality of young patients with acute myocardial infarction according to Estonian myocardial infarction registry

• Sex-specific management in patients with acute myocardial infarction and cardiogenic shock

13

• Should we fear primary graft failure in time of mechanical circulatory support?

• Spontaneous Coronary Artery Disease: a single center experience

• ST-segment elevation myocardial infarction in women: later diagnosis, worst outcome?

• Succinate plasma concentration during ventricular fibrillation and asphyxial cardiac arrest

• Symptom to door time interval has more effect on Ejection Fraction than door to balloon time after primary PCI

• Systemic to pulmonary systolic pressure ratio as a predictor for in-hospital mortality in intermediate- or high-risk pulmonary embolism - a retrospective analysis from a single center.

• Takotsubo syndrome:How to predict left ventricular dysfunction?

• Terminally ill heart failure patients in intensive cardiac care unit and anticipated directives.

• The association of B-lines in lung ultrasound with mortality in ST-elevation myocardial infarction

• The effect of myocardial inflammation on subpopulation of macrophages in virus-positive patients with ADHF

• The features of acute coronary syndrome in senile patients and centenarians

• The impact of electrocardiogram transmission and direct cath lab transfer on time to reperfusion in patients with acute ST-segment elevation myocardial infarction

• The impact of first contact-to-balloon time on intrahospital mortality in ST-elevation myocardial infarction presenting with out-of-hospital cardiac arrest and cardiogenic shock

• The importance of baseline lung ultrasound scanning in stable patients with heart failure.

• The importance of the 15-lead ECG recording in the diagnosis and treatment of acute myocardial infarction.

• The incidence of postoperative atrial fibrillation after coronary artery bypass graft

• The link between peripheral microcirculation and autonomic nervous system in patients admitted to the intensive care unit

• The predictive value of ACEF score for in-hospital mortality in patients with cardiogenic shock

• The quality of life in patients with coronary artery disease before and after revascularizatoin

• The risk factors for development of the no-reflow phenomenon in real clinic practice

• The role of cardiac magnetic resonance imaging in differentiating acute myocarditis from acute ST-elevation myocardial infarction

• The role of invasive diagnostics in the era of multi modality imaging.

• The S2PLIT score predicts mortality and rehospitalization in acutely decompensated heart failure

• The use of inotropes but not hyperchloremia, is an independent risk factor for acute renal injury in the postoperative period of cardiac surgery

• The usefulness of perioperative lactate blood levels in patients undergoing heart valve surgery

• Thrombolytic therapy in patients with high and intermediate risk pulmonary embolism

• Thrombotic complications and results in patients with venoarterial extracorporeal membrane oxigenation and cardiac prosthetic valves

• Ticagrelor versus clopidogrel in elderly patients with myocardial infarction: a real-life experience

• TLR-4 expression predicts mortality in patients with acute heart failure

• Total Ischemic Burden score based on st-segment deviations from the 12-lead ECG predicts mortality among patients with ischemic cardiomyopathy and reduced LVEF

• Transesophageal left atrial appendage pulsed tissue doppler echocardiography in acute cardioembolic cerebral stroke with normal sinus rhythm

• Transradial access through the anatomical snuffbox: Preliminary results of a feasibility study.

• Tricuspid annular plane systolic excursion (TAPSE) related to in-hospital mortality in ST-Elevation Myocardial Infarction (STEMI) patients

14

• Triggers of atrial fibrillation in the postoperative period in patients who died after non-cardiac surgery

• Troponin I in pulmonary thromboembolism: the power of discrimination

• Troponin T predicts cardiogenic shock requiring mechanical circulatory support in patients with valve disease

• Ultrasound guided arterial catheterization in critical patients with non-pulsatile continuous circulation conditions on ventricular assist devices or VA ECMO

• Ultrasound guided vascular catheterization in non-pulsatile continuous circulation conditions in critical patients with VA ECMO or ventricular assist devices

• Uric acid correlates with circulating mitochondrial DNA and predicts mortality in critically ill patients

• Value of speckle tracking Echocardiography in detection clinically silent left ventricular systolic dysfunction in diabetic patients

• Valvular and aortic involvement of patients with bicuspid aortic valve : an echocardiographic study

• Vascular access as a predictor of mortality in cardiogenic shock: 1-year follow-up

• Vascular Complications during Mechanical Circulatory Support in patients with Ventricular Septal Rupture complicating Acute Myocardial Infarction.

• Ventricular assist device as bridge to heart transplant. When should we include the patient in heart transplant waiting list?

• Ventricular fibrillation amplitude spectral area and end-tidal carbon dioxide for shock success and ROSC prediction. Is there a correlation?

• Very low LDL-C: insights from the real world

• What if worsening renal function in acutely decompensated heart failure patients is not so bad?

• Whole-body oxygen consumption during targeted temperature management at 33 degrees C versus 36 degrees C after out-of-hospital cardiac arrest.

• Will my patient with acute coronary syndrome develop heart failure?

• Will my patient with acute coronary syndrome end up in surgery? b. Other Scientific content

Title Speaker

Indication and selection of percutaneous mechanical support in cardiogenic shock complicating AMI

Vranckx Pascal

All you need to know about ventilation:Respiratory failure in cardiogenic shock Christian Hassager

Deciding end of life. Bonnefoy-Cudraz Eric

State-of-the-art lecture: optimal management of antithrombotic therapy in critically ill patients.

Gorog Diana

Optimal medical management: contemporary role of IV vasodilators and inotropes. Parissis John T

10 commandments of the pulmonary artery catheter with clear key messages. Carlos Alvira

Patient (and family) communications in the acute setting. Bueno Hector

Case 2: No ROSC after 10 minutes, should I already call the ECMO center? Belohlavek Jan

Pearls on cardiogenic shock diagnosis and management. The North American perspective.

Van Diepen Sean

Pearls on cardiogenic shock diagnosis and management. The European perspective. Uwe Zeymer

Intermediate - high risk PE - what do the guidelines say? Stavros Konstantinides